Otsuka Medical Devices Co., Ltd. Japan
Clinical trials sponsored by Otsuka Medical Devices Co., Ltd. Japan, explained in plain language.
A subsidiary of Otsuka Holdings focused on medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sound waves vs. high blood pressure: new device shows promise Results expected Dec 2026 (estimated)
-
New light therapy targets hard-to-treat blood cancer
Disease control Recruiting nowThis study tests a new treatment called OJP-001 for people with adult T-cell leukemia/lymphoma (ATLL) that has come back after prior therapy. The treatment uses a light-sensitive drug and a machine to treat the blood outside the body, aiming to kill cancer cells. The study will c…
Phase 1/2 • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can an app ease PTSD? new trial seeks answers
Symptom relief Recruiting nowThis study tests a software program designed to reduce symptoms of post-traumatic stress disorder (PTSD). About 52 adults with PTSD will use the software or a placebo version. Researchers will measure changes in PTSD severity using a standard scale over the study period.
Phase 2/3 • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC